261 related articles for article (PubMed ID: 1823309)
1. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
2. Serological and molecular studies of HLA in insulin-dependent diabetes mellitus in Sardinia.
La Nasa G; Carcassi C; Cirillo R; Mulargia M; Leone AL; Vacca A; Pizzati A; Boero R; Arras M; Porcella R
Dis Markers; 1990; 8(6):333-40. PubMed ID: 2101347
[TBL] [Abstract][Full Text] [Related]
3. The association between HLA class II haplotype with Graves' disease in Thai population.
Wongsurawat T; Nakkuntod J; Charoenwongse P; Snabboon T; Sridama V; Hirankarn N
Tissue Antigens; 2006 Jan; 67(1):79-83. PubMed ID: 16451208
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DR and -DQ genes with Graves disease in Koreans.
Park MH; Park YJ; Song EY; Park H; Kim TY; Park DJ; Park KS; Cho BY
Hum Immunol; 2005 Jun; 66(6):741-7. PubMed ID: 15993720
[TBL] [Abstract][Full Text] [Related]
5. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
7. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.
Congia M; Frau F; Lampis R; Frau R; Mele R; Cucca F; Muntoni F; Porcu S; Boi F; Contu L
Tissue Antigens; 1992 Feb; 39(2):78-83. PubMed ID: 1349446
[TBL] [Abstract][Full Text] [Related]
8. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
9. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
10. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
Montoya L; Saiz I; Rey G; Vela F; Clerici-Larradet N
Eur J Immunogenet; 1998 Oct; 25(5):329-37. PubMed ID: 9805655
[TBL] [Abstract][Full Text] [Related]
11. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population.
Yanagawa T; Mangklabruks A; Chang YB; Okamoto Y; Fisfalen ME; Curran PG; DeGroot LJ
J Clin Endocrinol Metab; 1993 Jun; 76(6):1569-74. PubMed ID: 8501164
[TBL] [Abstract][Full Text] [Related]
12. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
Yarman S; Oguz F; Carin M
Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
[TBL] [Abstract][Full Text] [Related]
14. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.
Maciel LM; Rodrigues SS; Dibbern RS; Navarro PA; Donadi EA
Thyroid; 2001 Jan; 11(1):31-5. PubMed ID: 11272094
[TBL] [Abstract][Full Text] [Related]
15. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
16. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
18. Classic Kaposi's sarcoma in Sardinia: HLA positive and negative associations.
Masala MV; Carcassi C; Cottoni F; Mulargia M; Contu L; Cerimele D
Int J Dermatol; 2005 Sep; 44(9):743-5. PubMed ID: 16135142
[TBL] [Abstract][Full Text] [Related]
19. Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease.
Cuddihy RM; Bahn RS
J Clin Endocrinol Metab; 1996 Feb; 81(2):847-9. PubMed ID: 8636314
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DR tissue types with Graves' disease in Taiwan.
Tsai KS; Hsieh RP; Chang CC; Chen FW; Lee SC
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):336-41. PubMed ID: 2794934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
